Efficacy of trametinib in a metastatic urothelial carcinoma patient with a BRAF mutation

MLA

Hiroyuki Karasawa, et al. “Efficacy of Trametinib in a Metastatic Urothelial Carcinoma Patient with a BRAF Mutation.” IJU Case Reports, vol. 7, no. 5, Sept. 2024, pp. 375–78. EBSCOhost, https://doi.org/10.1002/iju5.12759.

APA

Hiroyuki Karasawa, Yota Yasumizu, Takeo Kosaka, Tatsunori Shimoi, & Mototsugu Oya. (2024). Efficacy of trametinib in a metastatic urothelial carcinoma patient with a BRAF mutation. IJU Case Reports, 7(5), 375–378. https://doi.org/10.1002/iju5.12759

Chicago

Hiroyuki Karasawa, Yota Yasumizu, Takeo Kosaka, Tatsunori Shimoi, and Mototsugu Oya. 2024. “Efficacy of Trametinib in a Metastatic Urothelial Carcinoma Patient with a BRAF Mutation.” IJU Case Reports 7 (5): 375–78. doi:10.1002/iju5.12759.